Wells Fargo’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $104 | Hold |
|
|||||
|
2024
Q3 | $976 | Hold |
|
|||||
|
2024
Q2 | $2.34K | Sell |
|
|||||
|
2024
Q1 | $3.3K | Buy |
|
|||||
|
2023
Q4 | $4.2K | Sell |
|
|||||
|
2023
Q3 | $2.53K | Sell |
|
|||||
|
2023
Q2 | $2.35K | Sell |
|
|||||
|
2023
Q1 | $1.99K | Buy |
|
|||||
|
2022
Q4 | $2.51K | Buy |
|
|||||
|
2022
Q3 | $4K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $88K | Buy |
|
|||||
|
2021
Q3 | $1K | Hold |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $67K | Sell |
|
|||||
|
2020
Q4 | $827K | Sell |
|
|||||
|
2020
Q3 | $724K | Sell |
|
|||||
|
2020
Q2 | $886K | Buy |
|
|||||
|
2020
Q1 | $135K | Sell |
|
|||||
|
2019
Q4 | $181K | Sell |
|
|||||
|
2019
Q3 | $287K | Sell |
|
|||||
|
2019
Q2 | $274K | Sell |
|
|||||
|
2019
Q1 | $293K | Buy |
|
|||||
|
2018
Q4 | $138K | Buy |
|
|||||
|
2018
Q3 | $137K | Sell |
|
|||||
|
2018
Q2 | $191K | Buy |
|
|||||
|
2018
Q1 | $235K | Buy |
|
|||||
|
2017
Q4 | $143K | Sell |
|
|||||
|
2017
Q3 | $253K | Buy |
|
|||||
|
2017
Q2 | $227K | Hold |
|
|||||
|
2017
Q1 | $225K | Buy |
|